Showing results (211-220 of 238) with videos related to
Sort By:
Pageof 24
Brain : a Journal of Neurology|September 7, 2014
Serum microRNAs in patients with genetic amyotrophic lateral sclerosis and pre-manifest mutation carriersAxel Freischmidt, Kathrin Müller, Lisa Zondler, et al.Journal of Neurology, Neurosurgery, and Psychiatry|October 13, 2018
Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosisFederico Verde, Petra Steinacker, Jochen H Weishaupt, et al.Trials|May 3, 2020
Peer support for people with severe mental illness versus usual care in high-, middle- and low-income countries: study protocol for a pragmatic, multicentre, randomised controlled trial (UPSIDES-RCT)Galia S Moran, Jasmine Kalha, Annabel S Mueller-Stierlin, et al.Cell Reports|November 28, 2019
In Vivo Protein Complementation Demonstrates Presynaptic α-Synuclein Oligomerization and Age-Dependent Accumulation of 8-16-mer Oligomer SpeciesMartin Kiechle, Bjoern von Einem, Lennart Höfs, et al.The Journal of Experimental Medicine|January 13, 2019
Heterozygous Tbk1 loss has opposing effects in early and late stages of ALS in miceDavid Brenner, Kirsten Sieverding, Clara Bruno, et al.Ebiomedicine|March 14, 2023
Metabolic alterations precede neurofilament changes in presymptomatic ALS gene carriersJohannes Dorst, Patrick Weydt, David Brenner, et al.Shock (Augusta, Ga.)|February 21, 2018
Protective Effects of the Complement Inhibitor Compstatin CP40 in Hemorrhagic ShockMartijn van Griensven, Daniel Ricklin, Stephanie Denk, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 10, 2025
Early increase of the synaptic blood marker β-synuclein in asymptomatic autosomal dominant Alzheimer's diseasePatrick Oeckl, Benjamin Mayer, Randall J Bateman, et al.Neuro-Oncology Advances|August 11, 2021
A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3Marc-Eric Halatsch, Richard E Kast, Georg Karpel-Massler, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 31, 2021
Quantifying progression in primary progressive aphasia with structural neuroimagingJolina Lombardi, Benjamin Mayer, Elisa Semler, et al.Pageof 24